Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1.

Intraneuronal aggregates of hyperphosphorylated tau proteins, referred to as pathological tau, are found in brain areas of demented patients affected by numerous different neurodegenerative disorders. We previously described a particular biochemical profile of pathological tau proteins in myotonic dystrophy type 1 (DM1). This multisystemic disorder is characterized by an unstable CTG repeat expansion in the 3'-untranslated region of the DM protein kinase gene. In the human central nervous system, tau proteins consist of six isoforms that differ by the presence or absence of the alternatively spliced exons 2, 3 and 10. Here we show that the pattern of tau isoforms aggregated in DM1 brain lesions is characteristic. It consists mainly of the aggregation of the shortest human tau isoform. A disruption in normal tau isoform expression consisting of a reduced expression of tau isoforms containing the exon 2 was observed at both the mRNA and protein levels. Large expanded CTG repeats were detected and showed marked somatic heterogeneity between DM1 cases and in cortical brains regions analysed. Our data suggest a relationship between the CTG repeat expansion and the alteration of tau expression showing that DM1 is a peculiar tauopathy.

[1]  A. Hartmann,et al.  The STAR/GSG Family Protein rSLM-2 Regulates the Selection of Alternative Splice Sites* , 2001, The Journal of Biological Chemistry.

[2]  T. Ashizawa,et al.  RNA CUG Repeats Sequester CUGBP1 and Alter Protein Levels and Activity of CUGBP1* , 2001, The Journal of Biological Chemistry.

[3]  S. Takashima,et al.  Developmental expression of myotonic dystrophy protein kinase in brain and its relevance to clinical phenotype , 2000, Acta Neuropathologica.

[4]  R. J. White,et al.  Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. , 2000, Science.

[5]  B. Byrne,et al.  Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy , 2000, The EMBO journal.

[6]  A. Delacourte,et al.  Tau pathology: a marker of neurodegenerative disorders , 2000, Current opinion in neurology.

[7]  Patrick R. Hof,et al.  Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.

[8]  T. Arendt,et al.  Analysis of the molecular heterogeneity of the microtubule-associated protein tau by two-dimensional electrophoresis and RT-PCR. , 2000, Brain research. Brain research protocols.

[9]  G. Schellenberg,et al.  Determinants of 4-Repeat Tau Expression , 2000, The Journal of Biological Chemistry.

[10]  G. Tiscornia,et al.  Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios. , 2000, Molecular cell.

[11]  C. Junien,et al.  Transgenic mice carrying large human genomic sequences with expanded CTG repeat mimic closely the DM CTG repeat intergenerational and somatic instability. , 2000, Human molecular genetics.

[12]  Y. Chai,et al.  Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts , 2000, Nature Genetics.

[13]  T. Cooper,et al.  New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1) , 2000, Neurology.

[14]  B. Wieringa,et al.  Constitutive and regulated modes of splicing produce six major myotonic dystrophy protein kinase (DMPK) isoforms with distinct properties. , 2000, Human molecular genetics.

[15]  M. Siciliano,et al.  Dramatic, expansion-biased, age-dependent, tissue-specific somatic mosaicism in a transgenic mouse model of triplet repeat instability. , 2000, Human molecular genetics.

[16]  S. Stamm,et al.  Complex Regulation of Tau Exon 10, Whose Missplicing Causes Frontotemporal Dementia , 2000, Journal of neurochemistry.

[17]  M. Guazzelli,et al.  Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits. , 1999, Journal of neuropathology and experimental neurology.

[18]  E. Hoffman,et al.  Myotonic dystrophy: tissue-specific effect of somatic CTG expansions on allele-specific DMAHP/SIX5 expression. , 1999, Human molecular genetics.

[19]  C. Angelini,et al.  Reduction of the DM-associated homeo domain protein (DMAHP) mRNA in different brain areas of myotonic dystrophy patients , 1999, Neuromuscular Disorders.

[20]  S. Love,et al.  Microtubule-associated protein tau, heparan sulphate and α-synuclein in several neurodegenerative diseases with dementia , 1999, Acta Neuropathologica.

[21]  A. Grover,et al.  5′ Splice Site Mutations in tau Associated with the Inherited Dementia FTDP-17 Affect a Stem-Loop Structure That Regulates Alternative Splicing of Exon 10* , 1999, The Journal of Biological Chemistry.

[22]  G. Schellenberg,et al.  Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Delacourte,et al.  The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease , 1999, Neurology.

[24]  P. Hof,et al.  Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration , 1999, Acta Neuropathologica.

[25]  A. Delacourte,et al.  Neurofibrillary Degeneration in Progressive Supranuclear Palsy and Corticobasal Degeneration , 1999, Journal of neurochemistry.

[26]  John X. Morris,et al.  Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. , 1998, Science.

[27]  W. Kamphorst,et al.  Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau. , 1998, The American journal of pathology.

[28]  A Klug,et al.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  T. Cooper,et al.  Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. , 1998, Science.

[30]  A. Delacourte,et al.  Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their τ isoform distribution and phosphorylation , 1998, Annals of neurology.

[31]  S. Yen,et al.  Microtubule-Associated Protein Tau: Biochemical Modifications, Degradation, and Alzheimer's Disease , 1998 .

[32]  A. Delacourte,et al.  Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases , 1997, FEBS letters.

[33]  R. Moxley,et al.  Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene , 1997, Nature Genetics.

[34]  A. Delacourte,et al.  Two‐Dimensional Characterization of Paired Helical Filament‐Tau from Alzheimer's Disease: Demonstration of an Additional 74‐kDa Component and Age‐Related Biochemical Modifications , 1997, Journal of neurochemistry.

[35]  J. Brook,et al.  Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[36]  D. Housman,et al.  Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[37]  A. Delacourte,et al.  Normal and pathological Tau proteins as factors for microtubule assembly. , 1997, International review of cytology.

[38]  M. Goedert,et al.  Pick’s disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment , 1996, Acta Neuropathologica.

[39]  C. Angelini,et al.  Prediction of myotonic dystrophy clinical severity based on the number of intragenic [CTG]n trinucleotide repeats. , 1996, American journal of medical genetics.

[40]  A. Delacourte,et al.  Specific tau variants in the brains of patients with myotonic dystrophy , 1996, Neurology.

[41]  S. Tsujino,et al.  Small increase in triplet repeat length of cerebellum from patients with myotonic dystrophy , 1996, Human Genetics.

[42]  A. Delacourte,et al.  AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. , 1996, Brain research. Molecular brain research.

[43]  P. Hof,et al.  Specific Pathological Tau Protein Variants Characterize Pick's Disease , 1996, Journal of neuropathology and experimental neurology.

[44]  R. Korneluk,et al.  Characterization of large CTG repeat expansions in myotonic dystrophy alleles using PCR , 1996, Human mutation.

[45]  A. Delacourte,et al.  Isoelectric point differentiates PHF-tau from biopsy-derived human brain tau proteins. , 1995, Neuroreport.

[46]  K. Kosik,et al.  Relative exon affinities and suboptimal splice site signals lead to non-equivalence of two cassette exons. , 1995, Nucleic acids research.

[47]  J. Trojanowski,et al.  Detection of Phosphorylated Ser262 in Fetal Tau, Adult Tau, and Paired Helical Filament Tau (*) , 1995, The Journal of Biological Chemistry.

[48]  T. Ashizawa,et al.  Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: small pool PCR analyses. , 1995, Human molecular genetics.

[49]  C. Richards,et al.  Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent. , 1995, American journal of human genetics.

[50]  A. Sawa,et al.  Molecular diversity at the carboxyl terminus of human and rat tau. , 1994, Brain research. Molecular brain research.

[51]  E. Sadot,et al.  Complete sequence of 3'-untranslated region of Tau from rat central nervous system. Implications for mRNA heterogeneity. , 1994, Journal of molecular biology.

[52]  P. Turnpenny,et al.  Intelligence quotient profile in myotonic dystrophy, intergenerational deficit, and correlation with CTG amplification. , 1994, Journal of medical genetics.

[53]  R. Moxley,et al.  Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes , 1994, Annals of neurology.

[54]  K. Kosik,et al.  Structure and novel exons of the human tau gene. , 1992, Biochemistry.

[55]  L. Surh,et al.  The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy. , 1992, Journal of medical genetics.

[56]  E. Boerwinkle,et al.  Anticipation in myotonic dystrophy , 1992, Neurology.

[57]  T. Ashizawa,et al.  Characterization of a YAC and cosmid contig containing markers tightly linked to the myotonic dystrophy locus on chromosome 19. , 1992, Genomics.

[58]  C. Amemiya,et al.  Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. , 1992, Science.

[59]  T. Ashizawa,et al.  An unstable triplet repeat in a gene related to myotonic muscular dystrophy. , 1992, Science.

[60]  David E. Housman,et al.  Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member , 1992, Cell.

[61]  C. Amemiya,et al.  Cloning of the essential myotonic dystrophy region and mapping of the putative defect , 1992, Nature.

[62]  David E. Housman,et al.  Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy , 1992, Nature.

[63]  J. Trojanowski,et al.  A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. , 1991, Science.

[64]  M. Goedert,et al.  Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. , 1990, The EMBO journal.

[65]  M. Matsunaga,et al.  Topography of Alzheimer's neurofibrillary change distribution in myotonic dystrophy. , 1990, Clinical neuropathology.

[66]  R. A. Crowther,et al.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease , 1989, Neuron.

[67]  J. Geraedts,et al.  Anticipation in myotonic dystrophy: fact or fiction? , 1989, Brain : a journal of neurology.

[68]  Kenneth S. Kosik,et al.  Developmentally regulated expression of specific tau sequences , 1989, Neuron.

[69]  S. Mitake,et al.  [Development of Alzheimer neurofibrillary changes in two autopsy cases of myotonic dystrophy]. , 1989, Rinsho shinkeigaku = Clinical neurology.

[70]  R. Crowther,et al.  Cloning and sequencing of the cDNA encoding an isoform of microtubule‐associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. , 1989, The EMBO journal.

[71]  A. Delacourte,et al.  Alzheimer??s disease: tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments , 1987 .

[72]  D. Selkoe,et al.  Microtubule-associated protein tau (? ) is a major antigenic component of paired helical filaments in Alzheimer disease , 1987 .

[73]  D. Selkoe,et al.  Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[74]  H. Wiśniewski,et al.  Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. , 1986, The Journal of biological chemistry.

[75]  A. Delacourte,et al.  [Biochemical characterization of an immune serum which specifically marks neurons in neurofibrillary degeneration in Alzheimer's disease]. , 1986, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[76]  M. Kirschner,et al.  Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. , 1977, Journal of molecular biology.

[77]  M. Kirschner,et al.  Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. , 1977, Journal of molecular biology.

[78]  U. K. Laemmli,et al.  Maturation of the head of bacteriophage T4. II. Head-related, aberrant tau-particles. , 1973, Journal of molecular biology.

[79]  M. Kidd.  Paired Helical Filaments in Electron Microscopy of Alzheimer's Disease , 1963, Nature.